Zimmer Biomet Holdings (ZBH) EBT Margin Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -480.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -176.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 1,391.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 2,114.00 |
| 10 | Zimmer Biomet Holdings | 18.10 Bn | 17.68 Bn | 1.51 Bn | -122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.00 |
| Dec 31, 2025 | -4,752.00 |
| Sep 30, 2025 | 331.00 |
| Jun 30, 2025 | -38.00 |
| Mar 31, 2025 | 591.00 |
| Dec 31, 2024 | 1,498.00 |
| Sep 30, 2024 | 131.00 |
| Jun 30, 2024 | 546.00 |
| Mar 31, 2024 | -198.00 |
| Dec 31, 2023 | -283.00 |
| Sep 30, 2023 | -76.00 |
| Jun 30, 2023 | 3,290.00 |
| Mar 31, 2023 | 4,391.00 |
| Dec 31, 2022 | -442.00 |
| Sep 30, 2022 | 88.00 |
| Jun 30, 2022 | 414.00 |
| Mar 31, 2022 | -868.00 |
| Dec 31, 2021 | 233.00 |
| Sep 30, 2021 | 295.00 |
| Jun 30, 2021 | -75.00 |